Lusutrombopag

CHEMBL2107831 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

591.5 g/mol

LogP

7.7

Phase

4

A small-molecule thrombopoietin receptor agonist used to treat low platelet counts in adults with chronic liver disease preparing for a scheduled procedure. It stimulates the bone marrow to produce more platelets.

Peso Molecular

591,5000 g/mol

LogP

7,70

TPSA

126,00 Å²

Regra dos 5 de Lipinski

Reprovado

Áreas Terapêuticas

Hematology Hepatology

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\C)C(=O)O)c(Cl)c3)n2)c1OC

InChI

InChI=1S/C29H32Cl2N2O5S/c1-5-6-7-8-12-38-18(3)20-10-9-11-21(26(20)37-4)25-16-39-29(32-25)33-27(34)19-14-23(30)22(24(31)15-19)13-17(2)28(35)36/h9-11,13-16,18H,5-8,12H2,1-4H3,(H,35,36)(H,32,33,34)/b17-13+/t18-/m0/s1

Molecular Formula

C29H32Cl2N2O5S

HBD / HBA

2 / 7

Ligações Rotacionáveis

13

Átomos Pesados

39

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A small-molecule thrombopoietin receptor agonist used to treat low platelet counts in adults with chronic liver disease preparing for a scheduled procedure. It stimulates the bone marrow to produce more platelets.

Yes, Lusutrombopag is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2107831. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 49843517. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-08-20.

PillFYI

Procura informações acessíveis para o paciente?

Lusutrombopag no PillFYI

Estrutura

Dados Rápidos

Fórmula: C29H32Cl2N2O5S
Sinônimos: 1

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.